Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia

Abstract

To purchase or authenticate to the full-text of this article, please visit this link: http://onlinelibrary.wiley.com/doi/10.1111/bjh.14063/abstract Byline: Shaun Fleming, Doen Ming Ong, Kathryn Jackson, Sharon Avery, Peter Mollee, Paula Marlton, Glen Kennedy, Andrew H. Wei Keywords: AML ; acute leukaemia; residual disease; prognostic factors ***** No abstract is available for this article. Article Note: Denotes equal first authors. CAPTION(S): Fig S1. Patients with resistant AML (no CR or CRi after cycle 1 of induction) were grouped according to the reduction in bone marrow blasts compared to baseline assessed 4 weeks after commencing intensive induction chemotherapy. Table SI. Patient characteristics. Table SII. Multivariable analysis identifying independent factors for overall survival by PR. Multivariable analysis identifying independent factors for overall survival by mPR.Item Citation: British Journal of Haematology. April 2017, Vol. 177 Issue 2, p328, 3 p.Publication Type: Academic Journal; Source: British Journal of Haematology; Language: English; Publication Date: 20170401; Rights: Copyright 2017 Gale, Cengage Learning. All rights reserved., COPYRIGHT 2017 Blackwell Publishers Ltd.; Imprint: Wiley Subscription Services, Inc. <br />